retatrutide obesity phase 2 trial for Obesity: Weight-Loss Data Retatrutide for the treatment of
Description
Any central effect is not well-characterized yet, but it is a subject of ongoing research
In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time
Hashmi, thank you so much for joining us today
If and when retatrutide does get FDA approval, itll be especially important to monitor the drug while long-term safety and real patient side effects are still being established
This difference gives tirzepatide a unique mechanism of action
Changzhou Xuanming Pharmaceutical Technology Co., Ltd Order Online: +86-519-85525329 Email: [email protected] Email: [email protected] WhatsApp: +86 15995072465 WhatsApp: +86 13585347860 Peptides
